Replies to post #3040 on Adamis Pharmaceuticals Corp (ADMP)

[ShortsRClowns]

Great questions. Also, how do the following partner agreements below for 50% of NET PROFITS on majority of their product lines (Tempol, SYMJEPI and ZIMHI) play into it all? I also am just asking questions.

http://ir.adamispharmaceuticals.com/news-releases/news-release-details/adamis-pharmaceuticals-announces-license-commercialize-tempol

"Under the agreement, if any products (ie Tempol) are commercialized, net profits will be equally distributed between the parties."

http://ir.adamispharmaceuticals.com/news-releases/news-release-details/adamis-pharmaceuticals-provides-update-symjepi-products-and

"Under the terms of the Adamis/US WorldMeds agreement, US WorldMeds obtained U.S. rights to commercialize and distribute the SYMJEPI products, upon the termination of Sandoz’ commercial rights, and ZIMHI, if approved by the U.S. Food and Drug Administration, in exchange for an upfront payment and potential regulatory and commercial milestones totaling up to $26 million. Additionally, after deducting the supply price and certain other deductions, including an allocation for US WorldMeds sales and distribution expenses from net sales of the products, Adamis and US WorldMeds will share equally in the net profits, as defined in the agreement."